Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Pluristem Therapeutics, Inc. (PSTI)

Add PSTI Price Alert      Hide Sticky   Hide Intro
Moderator: midastouch017, n3m3sis
Search This Board: 
Last Post: 9/26/2017 4:40:58 PM - Followers: 142 - Board type: Free - Posts Today: 6


Pluristem Therapeutics Inc. (Nasdaq: PSTI)




Company Information:

Matam Advanced Technology Park
Building #20
Haifa 31905,  Israel

Tel :  +972-74-710-7171
Fax : +972-74-710-7172


CIK:  0001158780


Pluristem Therapeutics Inc. (NASDAQ: PSTI; DAX: PJT) is a clinical-stage biotechnology company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for a broad spectrum of diseases.

Pluristem derives its cell products from human placental cells. These cells are converted into PLacental eXpanded (PLX) cells, which secrete therapeutic proteins in response to signals produced by damaged tissues. Pluristem’s pipeline targets multiple indications involving inflammation and ischemia, including peripheral artery disease, muscle injury, preeclampsia, and graft versus host disease. PLX cells require no tissue matching prior to administration, making them an “off-the-shelf” product.

The company’s GMP-certified in-house manufacturing facilities allow it to efficiently produce commercial quantities of homogeneous, clinical-grade PLX cells. Pluristem is currently the only company manufacturing large quantities of placenta-based cell products using a 3D bioreactor. Driving these development efforts is a management team dedicated to shaping the future of the company and of placenta-based cell therapies. The Pluristem team has many decades of industry and research experience and draws on this as it continues to progress towards company goals. 



Clinical Program:

Recent News and Press:






Transfer Agent:

Nevada Agency and Transfer Company
50 W. Liberty St.
Suite 880
Reno, NV 89501


Investor Relations:   U.S.A.
Karine Kleinhaus, M.D., M.P.H.
Divisional VP, North-America




All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:


Cannabis Stocks News
Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PSTI News: Pluristem Receives Positive Feedback from FDA and EMA as Company Prepares for Phase III Trial of PLX-PAD to Support Recovery ... 07:00 AM
PSTI News: Current Report Filing (8-k) 09/18/2017 04:01:56 PM
PSTI News: U.S. FDA Grants Fast Track Designation to Pluristem's PLX-PAD for the Treatment of Critical Limb Ischemia (CLI) 09/18/2017 07:00:00 AM
PSTI News: Pluristem Strengthens Its Position in Asia, Awarded Two New Patents in Hong Kong for Critical Limb Ischemia and Muscle Regene... 09/13/2017 07:00:00 AM
PSTI News: Pluristem Reports Fourth Quarter and Fiscal 2017 Corporate and Financial Highlights 09/11/2017 08:17:04 AM
News News Alert: Pluristem Receives Positive Feedback from FDA and EMA as Company Prepares for Phase III Trial of PLX-PAD to Support Recovery ... 09/26/2017 07:00:00 AM
#7079   I Bet It's Even Lower Than That Now FDApproved 09/26/17 04:40:58 PM
#7078   short interest down again to just 835,000 as thesaud 09/26/17 04:31:06 PM
#7077   AH News just Out, How much Cash they bluehorsesho 09/26/17 04:19:33 PM
#7076   Again a perfect study design that will lead Melon4head 09/26/17 09:56:29 AM
#7075   Controller Working Hard To Keep The PPS At FDApproved 09/26/17 09:54:51 AM
#7074   Pluristem Receives Positive Feedback from FDA and EMA FDApproved 09/26/17 07:11:01 AM
#7073   Hematopoietic Stem Cell Transplantation (HSCT) Market is expected FDApproved 09/25/17 06:31:40 AM
#7072   Tuesday September 26, 2017... Dr. Raphael Gorodetsky Hadassah-Hebrew FDApproved 09/24/17 01:13:06 PM
#7071   Tuesday.10:15 AM....Sept 26, 2017 Cell & Gene Therapy FDApproved 09/24/17 01:11:59 PM
#7070   R18 is Not currently stockpiled, other companies are... bluehorsesho 09/23/17 08:08:32 PM
#7069   I see the ask is $2.50 and is bluehorsesho 09/23/17 04:45:42 PM
#7068   Breaking $1.85 Are You Serious ? Please FDApproved 09/23/17 03:47:22 PM
#7067   I am absolutely dumbfounded someone doesn't ..... bluehorsesho 09/23/17 03:39:02 PM
#7066   That Is The Best Daily Paper In The FDApproved 09/23/17 12:29:50 PM
#7065   Press on the link tomorrow, midastouch017 09/23/17 11:41:51 AM
#7064   Melon See My Post # 7037 For A FDApproved 09/23/17 11:23:57 AM
#7063   What is the significance of the date and Melon4head 09/23/17 10:57:50 AM
#7062   Published Again Today ! That's Unbelieveable ! Giddy-Up FDApproved 09/23/17 08:28:14 AM
#7061   and Tomorrow the date will be the 23 desktopdna 09/23/17 03:21:37 AM
#7059   The Lawyers Always Want To See A CYA FDApproved 09/22/17 07:17:55 PM
#7058   This info looks like contradictory Kronberg 09/22/17 05:32:47 PM
#7057   How Do You Know It Will Be The FDApproved 09/22/17 03:38:44 PM
#7056   and Tomorrow the date will be the 23 bluehorsesho 09/22/17 03:33:27 PM
#7055   That Is Correct ! The Interview Was Done FDApproved 09/22/17 03:23:32 PM
#7054   Yes, but day of the article is 24 voova99 09/22/17 03:20:10 PM
#7053   Did You See Today's Date In The Upper FDApproved 09/22/17 03:08:29 PM
#7052   Calm down.. voova99 09/22/17 03:06:13 PM
#7051   In Hebrew It Has Todays Date On The FDApproved 09/22/17 02:59:53 PM
#7050   This Is The Date In The Upper Right FDApproved 09/22/17 02:59:06 PM
#7049   Thank you Voova! midastouch017 09/22/17 02:55:45 PM
#7048   It was not published today!!! midastouch017 09/22/17 02:52:49 PM
#7047   Also, If It Was Published On August 24th FDApproved 09/22/17 02:48:34 PM
#7046   If That Is True ? How Come No FDApproved 09/22/17 02:46:32 PM
#7045   Midas is right. voova99 09/22/17 02:43:31 PM
#7043   There Is No Record Of That Interview Being FDApproved 09/22/17 02:06:42 PM
#7041   The article was published midastouch017 09/22/17 01:54:23 PM
#7040   Did Anybody Besides Me...Notice The Day The Interview FDApproved 09/22/17 12:51:14 PM
#7039   interesting. guess PSTI would qualify for 'life-threatening'...pretty broad jfk 09/22/17 11:13:22 AM
#7038   I understand House of Rep. has not done north40000 09/22/17 11:04:56 AM
#7037   Important Quotes From The Article. FDApproved 09/22/17 10:53:27 AM
#7036   enhanced profile, however the product still cannot be jfk 09/22/17 10:48:38 AM
#7035   AGREED!! n3m3sis 09/22/17 09:31:38 AM
#7034   Very nice find voova and very informative. n3m3sis 09/22/17 09:30:59 AM
#7033   Excellent article Voova99, those midastouch017 09/22/17 09:27:30 AM
#7032   Interesting article in Hebrew voova99 09/22/17 09:14:27 AM
#7031   Tuesday.10:15 AM....Sept 26, 2017 Cell & Gene FDApproved 09/21/17 06:46:45 PM
#7030   Is She Talking About Cell Therapy....Pluristem ? FDApproved 09/21/17 05:35:03 PM
#7029   One Would Think... PLX-R18 Will Be FAST-TRACKED As FDApproved 09/21/17 10:26:20 AM
#7028   This years Holidays came in midastouch017 09/21/17 09:16:35 AM
#7027   A little Higher..... n3m3sis 09/21/17 09:01:49 AM